ArticleBiology2026
Pre-Existing Heterogeneity Predicts Rare Proteostasis-Stress Programs Across Diverse Perturbations.
Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stress-associated transcriptional programs are common in single-cell perturbation data, but they are often treated as technical or experimental nuisance signals. Whether rare high-stress populations arise stochastically after perturbation or reflect outcomes associated with pre-existing cellular heterogeneity remains unclear. Herein, we build a cross-dataset stress-program prediction framework spanning 146,321 single cells and 926 perturbation-cell-line tasks. Untreated baseline heterogeneity, together with perturbation identity, predicted future rare integrated-stress burden across held-out cell-line-drug pairs (R2=0.742, Pearson r=0.862). Single-cell stress-program prediction generalized across leave-task-out, leave-cell-line-out and leave-perturbation-out splits; retained signal in leave-dataset-out evaluation; and collapsed to near-null performance under within-task label permutation. Independent validation datasets provided external support for the inferred stress axes: tunicamycin and thapsigargin activated unfolded protein response/integrated stress response (UPR/ISR) modules in bulk RNA sequencing (RNA-seq), thapsigargin expanded populations with high X-box binding protein 1 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.